This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Lebrun, P. Articles by Saint-Remy, J.-M. R. Search for Related Content PubMed PubMed Citation Articles by Lebrun, P. Articles by Saint-Remy, J.-M. R. Social Bookmarking                   What's this?

Injections of Complexes made of dsDNA and Specific Polyclonal Antibodies Extend MRL LPR Mouse Survival: a Pilot Study

Allergy and Clinical Immunology Unit, Institute of Cellular and Molecular Pathology; Saint-Luc Hospital, Catholic University of Louvain, Brussels, Belgium

Wivine Burny

Allergy and Clinical Immunology Unit, Institute of Cellular and Molecular Pathology; Saint-Luc Hospital, Catholic University of Louvain, Brussels, Belgium

Jean-Pierre Cosyns

Pathology Unit, Saint-Luc Hospital, Catholic University of Louvain, Brussels, Belgium

Jean-Marie R. Saint-Remy

Allergy and Clinical Immunology Unit, Institute of Cellular and Molecular Pathology; Saint-Luc Hospital, Catholic University of Louvain, Brussels, Belgium

Antibodies towards double-strain (ds) DNA are responsible for the development of lupus nephritis both in human and animal models. A method by which one would suppress the production of pathogenic idiotypes could therefore prevent the development of nephritis. To this end, we prepared polyclonal anti-dsDNA antibodies by immunoaffinity from a serum pool of MRL/MpJ-lpr mice, a strain that develops an early form of nephritis identical to its human counterpart. Antigen-antibody complexes were prepared by addition of dsDNA. Such complexes have the potential of altering the anti-DNA antibody response and boosting the production of specific anti-idiotypic antibodies. Two groups of 14 MRL lpr mice were treated by regular intraperitoneal injections of 10µg dsDNA-anti-dsDNA complexes or carrier buffer, starting at the age of 4 weeks, namely, prior to the appearance of nephritogenic anti-dsDNA IgG antibodies. We show here that such a treatment significantly extended the survival of treated mice compared with the control group. Five treated mice were still alive at month 11 compared with two in the control group. In addition, microscopic kidney examination at the time of death showed less lesions in the treated group compared with controls. This study indicates that complexes made of dsDNA and anti-dsDNA can delay the development of nephritis in the MRL lpr mouse strain.

Key Words: Lupus nephritis • MRL lpr mouse strain • Treatment • DNA-anti-DNA antibody complexes • Survival

Lupus, Vol. 3, No. 1, 47-53 (1994)
DOI: 10.1177/096120339400300110


CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				H. M. Bastian, G. S. Alarcon, J. M. Roseman, G. McGwin Jr, L. M. Vila, B. J. Fessler, J. D. Reveille, and for the LUMINA study group Systemic lupus erythematosus in a multiethnic US cohort (LUMINA) XL II: factors predictive of new or worsening proteinuria Rheumatology, April 1, 2007; 46(4): 683 - 689. [Abstract] [Full Text] [PDF]